SpringWorks Therapeutics Eulerpool naujienos

SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics akcijų naujienos

SpringWorks Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias SpringWorks Therapeutics naujienas mes pateikiame čia.

• rugsėjo 5 d. ·

  Yahoo
  SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares
• rugsėjo 4 d. ·

  TipRanks
  Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target
• rugsėjo 4 d. ·

  Thefly.com
  SpringWorks Therapeutics price target raised by $4 at JPMorgan, here's why
• rugpjūčio 29 d. ·

  SeekingAlpha
  Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2024 Update
• rugpjūčio 28 d. ·

  Seeking Alpha
  FDA accepts SpringWorks' application for mirdametinib for NF1-PN
• rugpjūčio 28 d. ·

  Yahoo
  FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• rugpjūčio 28 d. ·

  Seeking Alpha
  FDA accepts SpringWorks application for mirdametinib for NF1-PN
• rugpjūčio 28 d. ·

  TipRanks
  Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib
• rugpjūčio 28 d. ·

  GlobeNewswire
  FDA Grants Priority Review to SpringWorks Therapeutics? New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• rugpjūčio 28 d. ·

  Thefly.com
  SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib